Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisha Sun

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Molecular Cancer|December 29, 2022
Targeting SOST using a small-molecule compound retards breast cancer bone metastasisLisha Sun, Yixiao Zhang, Guanglei Chen, et al.
Nature Communications|September 1, 2016
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levelsArvindhan Nagarajan, Max C Petersen, Ali R Nasiri, et al.
Elife|July 28, 2025
Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot studyYu Zhang, Shuo Cao, Nan Niu, et al.
Signal Transduction and Targeted Therapy|October 8, 2025
CD8<sup>+</sup> TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patientsHaifeng Lin, Yi Han, Lei Guo, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Molecular Cancer|December 29, 2022
Targeting SOST using a small-molecule compound retards breast cancer bone metastasisLisha Sun, Yixiao Zhang, Guanglei Chen, et al.
Nature Communications|September 1, 2016
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levelsArvindhan Nagarajan, Max C Petersen, Ali R Nasiri, et al.
Elife|July 28, 2025
Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot studyYu Zhang, Shuo Cao, Nan Niu, et al.
Signal Transduction and Targeted Therapy|October 8, 2025
CD8<sup>+</sup> TILs in necrotic tumors after neoadjuvant immunochemotherapy predict outcomes in non-small-cell lung cancer patientsHaifeng Lin, Yi Han, Lei Guo, et al.
Pageof 11